Home . . Care and Services . . Cancer Care . . Cancer Registry
Cancer Registry
The Willmar Regional Cancer Center's Cancer Registry started in 1986. It allows lifetime follow-up of patients through physician contact on a yearly basis.
All Minnesota Cancer Registries are mandated by Minnesota Statute to forward a detailed record on each case of cancer to the Minnesota Cancer Surveillance System (MCSS). The MCSS systematically collects demographic and diagnostic information on all Minnesota residents with newly-diagnosed cancers.
- What data is collected?
- How is the data used?
What data is collected?
The Cancer Registry at Rice Memorial Hospital is responsible for the collection, management and analysis of data on patients diagnosed with cancer and/or treated at the hospital.
The following data is collected:
Demographic Information
Patient Medical History
Diagnostic Findings
Cancer Information
|
Cancer Staging
Cancer Treatment
Cancer Outcomes
|
Confidentiality
Confidentiality of patient identification information is strictly maintained. Individuals are not identified by name in any reports from the Cancer Registry.
Why collect cancer data?
For cancer program planning
- Identify facility and community needs
- Estimate market share
- Evaluate cost-effectiveness
- Allocate resources
- Evaluate access to care
- Target screening and intervention
Patient care and intervention
- Follow-up promotes reexamination
- Early detection
- Prevention
- Benchmarks for quality of cancer care
Research
- Epidemiologic risk factor analysis and monitor cancer trends
- Outcome assessment - survival analysis and treatment effectiveness
- Clinical trials - patient enrollment and grant application and renewal
Education
- Medical education - statistical reports of registry data help physicians who treat cancer patients to evaluate the success of specific cancer treatments, thus improving survival rates
- Public education - promotes screening programs
Follow Up
The Commission on Cancer, American College of Surgeons, requires cancer registries to have a current date of last contact and vital status (within 15 months) on 90% of all cases diagnosied with cancer and/or treated at Rice.
